| Regenerating islet-derived 4 (REG4) (Human) ELISA Kit | |
| A Biomarker for Cancer Research | |
| 1: Wang Q, et al. Oncogenic reg IV is a novel prognostic marker for glioma patient survival. Diagn Pathol. 2012 Jun 19;7:69. doi: 10.1186/1746-1596-7-69. 2: Numata M, Oshima T. Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers. World J Gastroenterol. 2012 Jul 21;18(27):3502-10 3: Kobunai T, et al. REG4, NEIL2, and BIRC5 gene expression correlates with gamma-radiation sensitivity in patients with rectal cancer receiving radiotherapy. Anticancer Res. 2011 Dec;31(12):4147-53. 4: Moon JH, et al. REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma. J Surg Oncol. 2012 Feb;105(2):189-94. 5: Wang F,et al. Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer. PLoS One. 2011 Apr 11;6(4):e18434. 6: Naito Y, et al. Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancer. PLoS One. 2012;7(11):e47545. 7: He XJ et al. REG4 contributes to the invasiveness of pancreatic cancer by upregulating MMP-7 and MMP-9. Cancer Sci. 2012 Dec;103(12):2082-91. |
|
| Human REG4 ELISA Kit Code No.: SK00636-01 Size: 96 T Price: $420.00 Standard range:3.125-200 pg/ml Sensitivity: 2 pg/ml Sample Type:serum, plasma Sample require: 100 ul per well Intra-CV: 4-6% Inter-CV: 8-10% Data Sheet: PDF |
|
| Name | Code No. |
Size |
Price ($) |
| REG4 (Human) ELISA Kit | 96 T |
420.00 |